Safety of TT-00420 Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer

Conditions:   Advanced Solid Tumors;   Triple Negative Breast Cancer Intervention:   Drug: TT-00420 Sponsor:   TransThera Biosciences Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials